Affiliation: Chair of the Risk Communication SIG, Netherlands
Priya Bahri completed studies in pharmacy and epidemiology as well as a PhD in quality management of healthcare. She holds certificates in strategic health communication and global health diplomacy.
She had gained work experience in hospital and community pharmacies and projects for health insurance companies and for the German international development agency before joining the European Medicines Agency (EMA) in 1996. There, she now is the Lead Pharmacovigilance and Risk Management Guidance and Policy.
Pro bono outside EMA, she is associated researcher at Utrecht University and an active member of the International Society of Pharmacovigilance (ISoP) and the International Society of Pharmacoepidemiology (ISPE). She is the editor of the book “Communicating about Risks and Safe Use of Medicines: Real Life and Applied Research” published by Springer Nature in 2020